[Aluminum content in individual components, used to prepare adult total parenteral nutrition mixtures in Argentine, and in comparison with international regulation]. / Contenido de aluminio en componentes individuales utilizados para preparar mezclas de nutrición parenteral en Argentina, y su comparación con la legislación internacional.

INTRODUCTION: Aluminum (Al) is a toxic element which may contaminate pharmaceutical products used as individual components to prepare total parenteral nutrition mixtures (TPN). OBJECTIVES: 1) to determine Al levels in the individual components used to prepare TPN mixtures; 2) to compare detected Al levels with those imposed by international regulations (FDA); 3) to calculate the total amount of Al administered to adult and children receiving those typical TPN mixtures. METHODS: Al was determined by Inductively Coupled Plasma- Atomic Emission Spectrometry (ICP-OES) (Perkin Elmer OPTIMA 5100 DV) in 44 individual products, from different labs and lots, belonging to 16 components available in Argentina: dextrose and amino acids for adult formulas and for pediatric formulas: lípids; potassium chloride; sodium chloride, magnesium sulfate; sodium phosphate; calcium gluconate; sodium glycerophosphate, zinc sulfate; multitrace elements; steril water (ampoules and great volume presentations). RESULTS: Al levels were detected in 43 of the 44 the studied components, except sterile water. The components of large volume presented between 249 y 1,580 µg Al/ L, between 4 and 180 times FDA established levels (25 µg Al/ L). Small volume components presented Al levels between 85 y 4,909 g/ L, not declared in labels. CONCLUSIONS: The highest amounts of Al were detected in calcium gluconate, sodium phosphate and multitrace elements. 2) Usually prescribed TPN mixtures would have higher Al levels than those accepted by FDA regulation; 3) The highest aluminum concentration was provided by dextrose, amino acids and lipids in adult TPN mixtures. In neonate TPN mixtures, Al highest amounts were provided by dextrose and calcium gluconate. The calculated concentration of Al in TPN mixtures was higher than those stipulated by international regulation (5 µg Al/kg (body weight)/ d). It would be advisable for manufacturers to declare the content of aluminum in the label, with the aim of avoiding toxicities which would compromise the critical patients' evolution.

Introducción: aluminio (Al) es un elemento tóxico que puede ser contaminante de productos farmacéuticos utilizados para preparar mezclas de nutrición parenteral (NP). Objetivos: 1) determinar la concentración de Al en componentes individuales utilizados para preparar mezclas de NP; 2) comparar las cantidades detectadas con los límites de la regulación internacional (FDA); 3) calcular la cantidad de Al administrada en fórmulas habituales de NP para neonatos, niños y adultos. Materiales y métodos: El Aluminio fue determinado por Espectroscopía de Emisión Atómica-Plasma-Inductivo de Argón (Perkin Elmer 5100 DV) en 44 productos comerciales, de diferentes laboratorios y lotes, correspondientes a 16 componentes individuales: dextrosa; aminoácidos para adultos y pediátricos; lípidos; cloruro de potasio; cloruro de sodio, sulfato de magnesio; fosfato de sodio; gluconato de calcio; glicerofosfato de sodio; sulfato de zinc; elementos multitraza; agua estéril en ampollas y de gran volumen. Resultados: Todos los componentes de gran volumen, excepto el agua, contenían entre 249 y 1.580 µg/L, superando entre 4 y 180 veces mas que los niveles establecidos por la FDA (25 µg/L). Los componentes de pequeño volumen contenían entre 85 y 4.909 µg/L, no declarados en los rótulos. Conclusiones: 1) La mayor cantidad de aluminio se encontró en el gluconato de calcio, fosfato de sodio y elementos multitraza. 2) Las mezclas de uso habitual para NP presentan niveles de Al mayores al límite de FDA. Los componentes que aportan mayor cantidad de aluminio en las mezclas de NP para adultos son: glucosa, aminoácidos y lípidos, pero en las de neonatos, el mayor aporte proviene de la dextrosa y gluconato de calcio. 3) En las mezclas de NP para neonatos, niños y adultos la cantidad de aluminio administrado por kg de peso supera la recomendación de FDA (5 µg/kg de peso /día). Los productos comerciales deberían declarar el contenido de Al para no comprometer la evolución de los pacientes graves.

[Pica diagnosis during pregnancy and micronutrient dificiency in Argentine women]. / Diagnóstico de pica durante el embarazo y deficiencia de micronutrientes en mujeres argentinas.

OBJECTIVE: To evaluate by biochemical parameters iron and zinc nutritional status in women with and without pica diagnosis during pregnancy. METHODOLOGY: During puerperium 109 women were evaluated at Fiorito Hospital, Argentina. Pica diagnosis was made in 42 women while 67 did not refer the practice. Fasting blood samples were obtained and analyzed in a hematology analyzer for values of red blood cells, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and hematocrit. Serum zinc and erythrocyte zinc was analyzed by atomic absorption spectrophotometry. RESULTS: Substances consumed during pica practice were: earth, ice, brick, paper, desinfectant and dog food. Women with pica diagnosis had higher a rate of family history of pica and personal antecedents of pica in childhood (OR: 15.9). Sociodemographic and anthropometric characteristics and neonatal birth weight were similar between both groups, although women with pica diagnosis had lower values in mean corpuscular volume (p = 0,008), mean corpuscular hemoglobin (p = 0,009) and erythrocyte zinc (0,008). Applying a logistic regression model, erythrocyte zinc was the only biochemical indicator associated with pica practice (p = 0,028). CONCLUSIONS: At puerperium, women with pica during pregnancy could have lower levels in biochemical parameters for iron and zinc status so we suggest that early diagnosis of pica could help to identify micronutrient deficient.

Diagnóstico de pica durante el embarazo y deficiencia de micronutrientes en mujeres argentinas / Pica diagnosis during pregnancy and micronutrient dificiency in Argentine women

Objetivo: Evaluar mediante indicadores bioquímicos el estado nutricional del hierro y el zinc en mujeres con y sin diagnóstico de pica durante el embarazo. Metodología: Se seleccionaron 109 puérperas del Hospital Fiorito, Argentina. El diagnostico de pica se realizó en 42 de ellas, en tanto que 67 mujeres no refirieron el hábito. Mediante un contador hematológico se determinaron los valores de hemoglobina, volumen corpuscular medio, hemoglobina corpuscular media, concentración de hemoglobina corpuscular media y hematocrito. Los niveles de zinc en plasma y en eritrocito se determinaron mediante espectrofotometría de absorción atómica. Resultados: Las sustancias consumidas durante la práctica de pica fueron: hielo, tierra, papel, ladrillo, desinfectante y alimento para perros. Las mujeres con diagnóstico de pica tuvieron prevalencias más elevadas de antecedentes familiares de pica y antecedentes personales de pica en la infancia (OR: 15,9). Las características sociodemográficas, antropométricas y el peso del neonato fueron similares en ambos grupos, no obstante las mujeres con diagnóstico de pica tuvieron valores más bajos en el volumen corpuscular medio (p = 0,008) la hemoglobina corpuscular media (p = 0,009) y el zinc en eritrocito (p = 0,008). Aplicando un modelo de regresión logística, el zinc eritrocitario continuó asociado al diagnóstico de pica (p = 0,028). Conclusiones: Durante el puerperio, las mujeres que presentaron pica durante el embarazo pueden tener indicadores bioquímicos más bajos del estado nutricional del hierro y el zinc, por lo se sugiere que el diagnóstico temprano de pica puede ayudar a identificar deficiencias de micronutrientes (AU)

Objective: To evaluate by biochemical parameters iron and zinc nutritional status in women with and without pica diagnosis during pregnancy. Metodology: During puerperium 109 women were evaluated at Fiorito Hospital, Argentina. Pica diagnosis was made in 42 women while 67 did not refer the practice. Fasting blood samples were obtained and analyzed in a hematology analyzer for values of red blood cells, hemoglobin, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, and hematocrit. Serum zinc and erythrocyte zinc was analyzed by atomic absorption spectrophotometry. Results: Substances consumed during pica practice were: earth, ice, brick, paper, desinfectant and dog food. Women with pica diagnosis had higher a rate of family history of pica and personal antecedents of pica in childhood (OR: 15.9). Sociodemographic and anthropometric characteristics and neonatal birth weight were similar between both groups, although women with pica diagnosis had lower values in mean corpuscular volume (p = 0,008), mean corpuscular hemoglobin (p = 0,009) and erythrocyte zinc (0,008). Applying a logistic regression model, erythrocyte zinc was the only biochemical indicator associated with pica practice (p = 0,028). Conclusiones: At puerperium, women with pica during pregnancy could have lower levels in biochemical parameters for iron and zinc status so we suggest that early diagnosis of pica could help to identify micronutrient deficient (AU)

[Influence of zinc administered by total parenteral nutrition on plasmatic zinc levels, on reactive C protein, on serum interleukin-6 and on serum interleukin-6 soluble receptor, in critical patients]. / Influencia del zinc administrado a pacientes críticos con nutrición parenteral sobre los niveles de zinc plasmático, proteína C reactiva, interleuquina-6 y receptor soluble de interleuquina-6.

OBJECTIVES: To study the interrelationship between serum Interleukin-6 (IL-6), serum Interleukin-6 soluble Receptor (IL-6 sR), C-Reactive Protein (C-RP), plasmatic Zinc levels (PlZn) and their response in relation to Zn administered by TPN, in critical patients. METHODS: 17 patients, receiving TPN as a consequence of acute pancreatitis (n = 4) or after a major abdominal surgery due to intestinal cancer (n = 7), intestinal fístula (n = 3), intestinal obstruction (n = 2) or intestinal íleus (n = 1) were studied. At the beginning (To) and at the end of the TPN administration (6-21 days) serum IL-6 and IL-6 sR were determined by ELISA; C-RP ultrasensitive (C-RP us) by inmunoturbidimetric method; Zn was determined in TPN and in plasma by Atomic Absorption Spectrometry. Characteristics of the patients were (mean +/- SD and ranges): age: 60.6 +/- 11.7 (37-77) years; BMI (kg/m(2)): 26.0 +/- 3.4 (19.9-34.0). RESULTS: The results (mean +/- standard deviation and ranges) were: Zn provided by TPN (mg/d): 6.1 +/- 2.0 (range 2.8 to 10.8). Biochemical levels were, at To and Tf, respectively: (mean+/-SD and ranges) were at To y Tf, respectively: Zn Pl (microg/dl): 104 +/- 46 (35-177); 120 +/- 55 (52-229); IL-6 (pg/mL) 93 +/- 74 (10-262); 117 +/- 180 (7-761); IL6sR (pg/mL): 1,012 +/- 322 (589-1855); 1,269 +/- 451 (631-2195); C-RP us (mg/L): 71 +/- 63 (2-196); 65 +/- 43 (0-137). There was no correlation between variations of IL6, IL6sR, C-RP, PlZn levels and the daily amount of Zn administered in the TPN mixtures. Two patients presented a bad evolution; they received 4.2 and 5.2 md/d of Zn and showed an increase of IL6 levels, maintained high levels of IL6sR but C-RP levels decreased. CONCLUSIONS: the range of 2.8 to 10.8 mg/d of Zn administered in TPN mixtures did not exacerbate the inflammatory response.

Influencia del zinc administrado a pacientes críticos con nutrición parenteral sobre los niveles de zinc plasmático, proteína C reactiva, interleuquina-6 y receptor soluble de interleuquina-6 / Influence of zinc administered by total parenteral nutrition on plasmatic zinc levels, on reactive C protein, on serum interleukin-6 and on serum interleukin-6 soluble receptor, in critical patients

Objetivos: Estudiar, en pacientes críticos, la respuesta de los niveles de Zn en plasma (ZnPl), de IL-6 sérica, del IL-6sR y de la PCR en relación al Zn administrado en la NPT, para evitar la deficiencia o el exceso de Zn. Métodos: 17 pacientes que recibieron NPT, por pancreatitis aguda o luego de una cirugía abdominal mayor. Al inicio (To) y a la finalización (Tf) de la NPT (6 a 21 días) se determinó en suero: IL-6 y IL-6 sR (ELISA); PCR (inmunoturbidimetría); ZnPl y Zn en NPT (Espectrometría de Absorción Atómica). Características físicas: edad, años (promedio ± DE y rangos): 60,6 ± 11,7 (37-77); BMI (kg/m2): 26,0 ± 3,4 (19,9-34,0). Resultados: Promedio ± DE (y rangos): aporte de Zn en la NPT: 6,1 ± 2,0 mg/día (2,8 a 10,8); parámetros bioquímicos, a To y Tf, respectivamente: Zn Pl (μg/dl): 104 ± 46 (35-177); 120 ± 55 (52-229); IL-6 (pg/mL) 93 ± 74 (10-262); 117 ± 180 (7-761); IL6sR (pg/mL): 1012 ± 322 (589-1.855); 1.269 ± 451 (631-2.195); PCR (mg/L): 71 ± 63 (2-196); 65 ± 43 (0-137). Dos pacientes, que fallecieron, incrementaron más de 4 veces los niveles de IL6, mantuvieron altos niveles de IL-6sR, pero disminuyendo los de PCR, recibiendo 4,2 y 5,2 mg/d de Zn. El 60% de los pacientes con evolución clínica favorable presentó una disminución de los niveles de IL6. Conclusiones: en los pacientes críticos, con evolución favorable, dosis de Zn de 2,8 a 10,8 mg/d en la NPT no exacerbaron la respuesta inflamatoria, evaluada mediante los niveles de IL-6, IL6sR y PCR (AU)

Objectives: To study the interrelationship between serum Interleukin-6 (IL-6), serum Interleukin-6 soluble Receptor (IL-6 sR), C-Reactive Protein (C-RP), plasmatic Zinc levels (PlZn) and their response in relation to Zn administered by TPN, in critical patients. Methods: 17 patients, receiving TPN as a consequence of acute pancreatitis (n = 4) or after a major abdominal surgery due to intestinal cancer (n = 7), intestinal fístula (n = 3), intestinal obstruction (n = 2) or intestinal íleus (n = 1) were studied. At the beginning (To) and at the end of the TPN administration (6-21days) serum IL-6 and IL-6 sR were determined by ELISA; C-RP ultrasensitive (C-RP us) by inmunoturbidimetric method; Zn was determined in TPN and in plasma by Atomic Absorption Spectrometry. Characteristics of the patients were (mean ± SD and ranges): age: 60.6 ± 11.7 (37-77) years; BMI (kg/m2): 26.0 ± 3.4 (19.9-34.0). Results: The results (mean ± standard deviation and ranges) were: Zn provided by TPN (mg/d): 6.1 ± 2.0 (range 2.8 to 10.8). Biochemical levels were, at To and Tf, respectively: (mean±SD and ranges) were at To y Tf, respectively: Zn Pl (μg/dl): 104 ± 46 (35-177); 120 ± 55 (52-229); IL-6 (pg/mL) 93 ± 74 (10-262); 117 ± 180 (7-761); IL6sR (pg/mL): 1,012 ± 322 (589-1855); 1,269 ± 451 (631-2195); C-RP us (mg/L): 71 ± 63 (2-196); 65 ± 43 (0-137). There was no correlation between variations of IL6, IL6sR, C-RP, PlZn levels and the daily amount of Zn administered in the TPN mixtures. Two patients presented a bad evolution; they received 4.2 and 5.2 md/d of Zn and showed an increase of IL6 levels, maintained high levels of IL6sR but C-RP levels decreased. Conclusions: the range of 2.8 to 10.8 mg/d of Zn administered in TPN mixtures did not exacerbate the inflammatory response (AU)

Relacion entre las cantidades de cobre y zinc administradas a pacientes graves con nutrición parenteral total y los niveles de cobre y zinc en plasma y eritrocitos / Relationship between the amount of copper and zinc given to critically ill patients on total parenteral nutrition and plasma and erythrocyte copper and zinc levels

Objetivos: Evitar tanto las complicaciones por deficiencia de zinc y de cobre como los efectos adversos del exceso en pacientes graves que requirieron nutrición parenteral, estudiando la relación entre las cantidades de zinc y de cobre administradas en las mezclas de nutrición parenteral y los cambios en algunos indicadores bioquímicos de los pacientes, con respecto a zinc y cobre. Pacientes y metodología: 29 pacientes graves, adultos, con pancreatitis o sometidos a cirugía mayor abdominal. Se determinó, al inicio y al final del tratamiento (5-21 días): cobre y zinc en las mezclas de nutrición parenteral administradas y en eritrocitos (GR), zinc en plasma y cobre en suero (Espectrometría de Absorción Atómica). Resultados (promedio ± DE, rangos: entre paréntesis): los valores de zinc y cobre en las mezclas de nutrición parenteral fueron (μg/mL): zinc: 4,2 ± 1,7 (1,8 a 9,3); cobre: 0,94 ± 0,66 (0,1 a 3,1); zinc plasmático (μg/dl): inicio 80 ± 45 (29-205); final: 122 ± 56 (37-229); zinc eritrocitario (μg/dl): inicio: 2.300 ± 1.070 (790-5280); final: 2.160± 920 (790-4.440); cobre sérico (μg/dl): inicio: 124 ± 35 (62-211); final: 128 ± 41 (60-238); cobre eritrocitario (μg/dl): inicio: 72 ± 39 (4-183); final: 70 ± 41 (9-156). Los cambios porcentuales de los niveles de zinc eritrocitario correlacionaron con el zinc (mg/d) en las mezclas de nutrición parenteral (r = 0,38). Las variaciones de cobre sérico y eritrocitario correlacionaron positivamente con los valores de cobre administrado (mg/d) en las mezclas de nutrición parenteral (r = 0,31 y 0,26, respectivamente). Conclusiones: Estos resultados evidenciaron que: 1) las determinaciones de zinc eritrocitario, cobre sérico o eritrocitario serían de utilidad para controlar los niveles de zinc y de cobre administrados en las mezclas de nutrición parenteral a los pacientes graves; 2) las dosis de zinc deberían ser menores a 8,1 mg/d, y 3) no sería aconsejable administrar dosis de cobre superiores a 1,2 mg/d (AU)

Objectives: Complications resulting from zinc and copper deficiency, or adverse effects from excessive zinc and copper intake should be avoided during total parenteral nutrition (TPN). This study was conducted on critically ill patients requiring TPN to determine the relationship between the zinc and copper levels of the TPN mixtures, patients' clinical progression, and changes in plasma levels of zinc, serum levels of copper, and erythrocyte levels of zinc and copper. Patients and methods: 29 adult critically ill patients following pancreatitis or after a major abdominal surgery were studied. Zinc and copper levels in TPN, plasmatic zinc levels, copper serum levels and erythrocyte levels of zinc and copper were determined at the onset and at the end of the treatment (5-21 days) (using Atomic Absorption Spectrometry). Results: The mean ± standard deviation (and ranges in parenthesis) of zinc and copper levels in TPN were (μg/mL): zinc: 4.2 ± 1.7 (1.8 a 9.3); copper: 0.94 ± 0.66 (0.1 a 3.1). Biochemical parameters at the onset and at the end of the treatment were, respectively: (μg/mL): plasmatic zinc: 80 ± 45 (29-205) and 122 ± 56 (37-229); erythrocyte zinc: 2,300 ± 1,070 (790-5,280) and 2,160 ± 920 (790-4,440); serum copper (μg/dL): 124 ± 35 (62-211) and 128 ± 41 (60- 238); erythrocyte copper (μg/dl): 72 ± 39 (4-183) and 70 ± 41 (9-156). Plasmatic and erythrocyte zinc levels did not correlated neither at the onset nor at the end of the treatment. Changes in erythrocyte zinc levels correlated with daily administered zinc (mg/d) in the parenteral nutrition (r = 0.38). Serum copper and erythrocyte copper showed significant correlation at the onset (p = 0.0005) and at the end of treatment (p = 0.008). Changes of serum or erythrocyte copper levels showed a significant correlation with daily administered copper (r = 0.31 and 0.26, respectively). Conclusions: These results show that: 1) determination of erythrocyte zinc and copper levels in these critically ill patients would help to control zinc and copper administration levels in TPN and avoid adverse effects; 2) TPN Zn levels should be less than 8.1 mg/d, and 3) TPN Cu levels higher than 1.2 mg/d would not be recommended (AU)

[Relationship between the amount of copper and zinc given to critically ill patients on total parenteral nutrition and plasma and erythrocyte copper and zinc levels]. / Relación entre las cantidades de cobre y zinc administradas a pacientes graves con nutrición parenteral total y los niveles de cobre y zinc en plasma y eritrocitos.

OBJECTIVES: Complications resulting from zinc and copper deficiency, or adverse effects from excessive zinc and copper intake should be avoided during total parenteral nutrition (TPN). This study was conducted on critically ill patients requiring TPN to determine the relationship between the zinc and copper levels of the TPN mixtures, patients' clinical progression, and changes in plasma levels of zinc, serum levels of copper, and erythrocyte levels of zinc and copper. PATIENTS AND METHODS: 29 adult critically ill patients following pancreatitis or after a major abdominal surgery were studied. Zinc and copper levels in TPN, plasmatic zinc levels, copper serum levels and erythrocyte levels of zinc and copper were determined at the onset and at the end of the treatment (5-21 days) (using Atomic Absorption Spectrometry). RESULTS: The mean+/-standard deviation (and ranges in parenthesis) of zinc and copper levels in TPN were (microg/mL): zinc: 4.2+/-1.7 (1.8 a 9.3); copper: 0.94+/-0.66 (0.1 a 3.1). Biochemical parameters at the onset and at the end of the treatment were, respectively: (microg/mL): plasmatic zinc: 80+/-45 (29-205) and 122+/-56 (37-229); erythrocyte zinc: 2,300+/-1,070 (790-5,280) and 2,160+/-920 (790-4,440); serum copper (microg/dL): 124+/-35 (62-211) and 128+/-41 (60- 238); erythrocyte copper (microg/dl): 72+/-39 (4-183) and 70+/-41 (9-156). Plasmatic and erythrocyte zinc levels did not correlated neither at the onset nor at the end of the treatment. Changes in erythrocyte zinc levels correlated with daily administered zinc (mg/d) in the parenteral nutrition (r=0.38). Serum copper and erythrocyte copper showed significant correlation at the onset (p=0.0005) and at the end of treatment (p=0.008). Changes of serum or erythrocyte copper levels showed a significant correlation with daily administered copper (r=0.31 and 0.26, respectively). CONCLUSIONS: These results show that: 1) determination of erythrocyte zinc and copper levels in these critically ill patients would help to control zinc and copper administration levels in TPN and avoid adverse effects; 2) TPN Zn levels should be less than 8.1 mg/d, and 3) TPN Cu levels higher than 1.2 mg/d would not be recommended.

[Zinc and copper content in individual components used to prepare pediatric total nutrition mixtures]. / Contenido de zinc y cobre en los componentes individuales de las mezclas para fórmulas pediátricas de nutrición parenteral total.

OBJECTIVES: 1) to determine zinc and copper levels of contamination in the individual component solutions used to prepare the pediatric total parenteral nutrition mixtures in Argentina; 2) to compare zinc and copper amounts prescribed by the physician with the true amount given to a neonate weighing 1.2 kg and to a child weighing 10 kg, who would receive total parenteral nutrition formulas prepared with those component solutions. MATERIALS AND METHODS: Zn and Cu were determined by atomic absorption spectrophotometry in 59 individual solutions belonging to 14 components chosen between the commercial products available in Argentina. RESULTS: zinc and copper, as contaminants, were found neither in the sterile water, nor in the potassium chloride or in the vitamin solutions. Zinc, but no copper, was detected in sodium chloride, manganese sulfate, chromium chloride and seleniose acid solutions. Zinc and copper were detected in dextrose, amino acids, calcium gluconate and lipid solutions at variable levels. Zinc sulfate solutions contained between 90.4% and 140% of the declared content and a variable contamination with copper. Copper sulfate solutions presented between 4% and 18% less the declared copper concentration and a variable contamination with zinc. Dextrose and lipid solutions presented the highest amount of zinc and copper. Therefore, the total parenteral mixtures prepared with the analyzed solutions must have had an excess of zinc and copper in relation to the prescription: ranging between 103% and 161% and between 7%-426% higher than the Zn and Cu amounts prescribed for neonates, respectively; the excess in the total parenteral nutrition for a child weighing 10 kg would ranged between 105% and 189% and between 7%-365% higher than the prescribed for Zn and Cu, respectively. CONCLUSIONS: 1) Nine components presented Zn and five Cu, both of them not declared in the label; 2) the usually prescribed total parenteral nutrition mixtures must have had a zinc and copper amount higher than the prescribed one according to international recommendations; 3) those figures would be safe in patients without complications, but it would be harmful in renal failure, hepatic compromise or colestasis mainly in pediatric patients; 4) It would be advisable to declare in the label the true content of zinc and copper, with the aim to avoid deficiencies and excess which would compromise the evolution of pediatric patients.

[Plasmatic and erythrocytic zinc and copper levels in critically ill patients on parenteral nutrition and their relationship with formulas content: preliminary study]. / Niveles plasmáticos y eritrocitarios de zinc y cobre en pacientes críticos con nutrición parenteral y su relación con el contenido de las fórmulas: estudio preliminar.

OBJECTIVES: To study in severe patients that required parenteral nutrition the relationship between Zn and Cu amounts present in formulas, the clinical course and changes in some biochemical parameters (plasmatic and erythrocytic Zn and Cu levels) during the parenteral nutrition therapy. PATIENTS AND METHODOLOGY: Five adult severe patients were studied, submitted to major abdominal surgery, and that required parenteral nutrition. Determinations were done for: 1) Zinc and copper in parenteral formulas; 2) in patients, at the beginning (T0) and at the end (Tf) of treatment, in erythrocytes: zinc (Zn-E) and cupper (Cu-E); in plasma, zinc (Zn-Pl) and in serum, cupper (Cu-S). Zinc and cupper were determined by means of atomic absorbance spectrometry. RESULTS: mean +/- standard deviation values and ranges (between brackets) were: parenteral formulas (microg/g): zinc: 0.6 +/- 1.1 (2.2 - 7.0); Cupper: 2.4 +/- 0.7 (0.5-3.7). Biochemical parameters: at T0 (n = 5): Zn-E (microg/mL): 21.6 +/- 10.0 (13.6-36.1); Zn-Pl (microg/dL): 88 +/- 72 (29-205); Cu-E (microg/dL): 113 +/- 22 (60-102); Cu-E (microg/dL): 139 +/- 29 (106 +/- 156); Cu-S (microg/dL): 172 +/- 20 (158-195). Individual values compared to reference ones (normal individual from Buenos Aires with adequate nutrition) indicated that the three patients with favorable course normalized Zn-Pl and Zn-E levels. However, Cu-S increased in the three cases and Cu-E in two of them. CONCLUSIONS: These results make clear that in the studied patients Zinc levels in parenteral formulas would be adequate to prevent deficiency while Copper levels could be too high.

Bone mass changes in vivo during the entire reproductive cycle in rats feeding different dietary calcium and calcium/phosphorus ratio content.

The purpose of this study was to quantify in vivo the impact of different dietary Ca contents on the maternal total skeleton and skeletal sub-areas in adult rats during pregnancy and lactation, using DXA. Twenty-four female Wistar rats (approximately 5 months old) were mated and divided into three groups (n = 8) and fed one of the following diets, varying only in Ca content (LCD: 0.14%, NCD: 0.6% or HCD: 1.2%). Pups were adjusted to 8-9 per dam. Maternal ionic calcium and in vivo bone mineral density (BMD) were measured at the beginning, after delivery and after weaning. Regardless of the diet, ionized calcium decreased from onset to weaning ( P < 0.05). At weaning, bone mass decreased 7.3% in NCD, 15% in LCD and 10.5% in HCD from initial values. Total skeleton, whole and proximal tibia and spine BMDs only decreased at delivery in the LCD group ( P < 0.05) but, irrespective of the diet, at weaning, they were lower compared to delivery and initial values ( P < 0.05). LCD group presented the lowest BMD in the proximal tibia and spine regions ( P < 0.05). At birth, pups did not present differences, however, at weaning, LCD pups reached the lowest body weight ( P < 0.05), NCD presented the highest body Ca content ( P < 0.05) and there were no differences between LCD and HCD. This in vivo study showed that regardless of the dietary calcium content, the maternal skeleton is slightly affected by pregnancy but severely affected by lactation. However, the degree of such response appears to depend not only on dietary Ca content but also on dietary Ca/P molar ratio.

Efecto del nivel de calcio de la dieta consumida durante gestación y lactancia sobre el zinc en sangre y hueso, en ratas / Effect of dietary calcium during pregnancy and lactation on zinc levels in blood and bone, in rats

The effect of dietary calcium (Ca) level on maternal zinc (Zn) nutritional status was studied. Female Wistar rats, weighing 250-350 g, were fed during pregnancy and lactation with an experimental diet containing/100 g different levels of calcium: 0.2 g (low calcium: LCa), 0.6 g (normal calcium: NCa) or 0.9 (high calcium: HCa). Maternal blood samples were drawn from the tail at delivery and at the end of lactation. Laboratory determinations were: Zn in whole blood (WB) at delivery and weaning; Zn (ZnF) and Ca (CaF) in the ashed femur at weaning. The results (mean +/- SEM) were: ZnWB (microgram/ml) at delivery and weaning: LCa: 8.73 +/- 1.05; 12.8 +/- 2.02; NCa: 3.49 +/- 0.19; 3.73 +/- 0.37; HCa: 3.21 +/- 0.19; 3.85 +/- 0.27. CaF (mg/100 mg): LCa: 19.2 +/- 0.8; NCa: 21.4 +/- 0.6; HCa: 20.4 +/- 1.1. ZnF (microgram/100 mg): LCa: 30.2 +/- 0.9; NCa: 24.1 +/- 0.3; HCa: 24.1 +/- 0.9. ZnWB was significantly higher in LCa (p < 0.0001) regarding NCa and Hca. ZnF showed an increase and CaF a decrease in LCa regarding NCa and HCa (p < 0.0001). There were no significant differences in ZnWB, ZnF and CaF between NCa and HCa These results show that: there was no detrimental effect when dietary Ca content was increased by 50 per cent above the normal requirements of the rat.; low dietary Ca during pregnancy and lactation produced an increase of Zn utilization, reflected in maternal blood Zn and in ZnF content.

[Zinc levels in term and preterm milk]. / Niveles de zinc en leche humana de término y pretérmino.

Zinc is an essential element, important for early growth and development, and immune competence, which deficiency might be especially critical in preterm infants. Since published data have shown that some preterm milks have abnormally low zinc values, we decided to measure zinc levels in term and preterm milk, in order to assess if they were within normal values and if there were differences between both groups. Samples from 24 preterm and 20 term mothers (mean gestational age, 30.9 + 0.5 and 39.5 + 0.2 weeks, respectively) were collected and kept at -20 degrees C until analyzed by atomic absorption spectrophotometry, prior wet ashing with nitric acid. Both term and preterm milk showed zinc values within normal levels. No significant differences were registered between them. A decreasing trend was observed along time, which was significant between colostrum and mature milk samples (ANOVA, p < 0.05). In the term group, zinc concentrations in colostrum and mature milk (microgram/mL) (mean +/- SEM) varied between 6.96 +/- 0.69 y 2.44 +/- 0.11, while in the preterm group the values were 6.20 +/- 0.89 y 2.28 +/- 0.54. According to our results, zinc values in human milk were comparable between preterm and term mothers.

Niveles de zinc en leche humana de término y pretérmino / Zinc levels in term and preterm milk

El zinc es un elemento esencial, muy importante para el crecimiento y desarrollo temprano y para una adecuada inmunocompetencia, cuya deficiencia puede ser especialmente crítica en neonatos prematuros. Algunos estudios han hallado valores anormalmente bajos de zinc en leche pretérmino. El objetivo de este trabajo fue determinar si los niveles de zinc en leche de término y pretérmino en nuestra población presentaban valores normales y si se observaban diferencias entre ambos tipos de leche, durante el primer mes de lactancia. Para ello, se analizaron muestras obtenidas de madres de 24 neonatos pretérmino y 20 de término (edad gestacional 30,9 ñ 0,5 y 39,5 ñ 0,2 semanas, respectivamente) Se mantuvieron a -20ºC hasta su análisis por espectrometría de absorción atómica, previa digestión con ácido nítrico. Tanto en la leche de término como en la pretérmino, los niveles de zinc estuvieron dentro de valores normales, sin que se registraran diferencias significativas entre estos dos tipos de leche. Se observó una tendencia decreciente en el tiempo, que fue significativa entre las muestras de calostro y las de leche madura (ANOVA, p<0,05). En el grupo de término, las concentraciones de zinc en calostro y leche madura (µg/mL) (X ñ ESM) variaron entre 6,96 ñ 0,69 y 2,44 ñ 0,11 mientras que en el grupo de pretérmino lo hicieron entre 6,20 ñ 0,89 y 2,28 ñ 0,54. Se concluye que en el contenido de zinc en la leche de pretérmino no fue significativamente menor que en la leche de término

Basal urinary zinc/creatinine ratio as an indicator of dietary zinc intake in healthy adult women.

OBJECTIVE: To study, in healthy women, the correlation between the basal urinary zinc/creatinine ratio and dietary zinc intake. SUBJECTS: A group of 36 healthy female University students was evaluated. Mean age and body weight were, respectively, 25.6+/-3.3 years and 54.4+/-7.0 kg. METHODS: Basal urine was collected; Zn was determined by AAS and Creatinine (Creat) by the Jaffe method. A nutritional survey of seven days was recorded. Mean daily dietary intake of energy (DE) and zinc (DZn) were calculated according to the INCAP and English or German Food Composition Tables, respectively. RESULTS: Mean dietary daily intake were as follows (x +/- SD): Energy (kcal): 1606+/-570; zinc (mg): 9.1+/-3.8; basal urine Zn/Creat ratio: 0.41+/-0.24. Individual values of the Zn/Creat ratio correlated with dietary Zn (r=0.481, p=0.0339); data grouped according to ranges of dietary Zn fit the following equation: Zn/Creat=0.160+/-0.034 DZn (mg/day); (r=0.870, p=0.00497). CONCLUSIONS: These results showed that the basal urinary Zn/Creat ratio could be a useful indicator of dietary Zn intake in healthy adult women.

[Nutritional status of surgical patients without apparent nutritional compromise]. / Estado nutricional de pacientes quirúrgicos sin aparente compromiso nutricional.

Nutritional status of 80 preoperative patients from programmed surgeries of hernias and lithiasis was studied by anthropometric and biochemical parameters. Nutritional deficiencies related to pathology were not expected in these patients. Results were as follows: 77% of the population showed overweight, being 15% obese. Prevalent protein intake, evaluated by the urea nitrogen/creatinine ratio, was adequate in 87.5% of the patients; however, patients presented 72% of albumin, 52% of prealbumin and 50% of RBP below reference values. Transferrin, ceruloplasmin, alpha 2-macroglobulin and haptoglobin were not decreased. Assessment of vitamin A, carotenes and vitamin C showed plasmatic levels below reference values in 16% of the patients for vitamin A, 5% for carotenes and 27% for vitamin C. Respect to calcium status, data of calcium/creatinine ratio show deficiency in 45% of the population. Respect to iron, the nutritional status was in general adequate, patients at risk being 5% by Htc, 11% by Hb, 5% by TS% and 12.5% by FEP, women showed over twice abnormal values than men. Although some isolated relations were observed, in this population sex, age and pathology were variable that did not affect in a relevant way the nutritional status. In spite of the individual analysis of each nutrient did not show important deficiencies, the analysis by patient showed that only a few of them (7%) presented an optimal biochemical profile with all the studied parameters within the reference values.

Análisis de los valores de protoporfirina eritrocitaria libre, en escolares de una zona urbana de Buenos Aires / Free erythrocyte protoporphyrins study in school-children of Buenos Aires city

El aumento de la Protoporfirina Eritrocitaria Libre (FEP), detecta deficiencias marginales de hierro (Fe), constituyendo un indicador precoz que, a las características de simplicidad y rapidez, une las de su determinación en una muestra mínima de sangre de fácil conservación. Pese a esta ventajas, ha sido poco utilizada en estudios poblacionales, salvo en USA, donde su aplicación en la II Nutritional and National Health Examination Survey (NANHES II), ha permitido establecer valores normativos para las diferentes edades. En este trabajo, se aporta información sobre los valores hallados en una población escolar (n = 102), perteneciente al nivel socio-económico bajo y medio-bajo de la ciudad de Buenos Aires, en la que se determinó Hematocrito (Hto) y FEP (según Piomelli). Los resultados, expresados como FEP/dL de glóbulos rojos (FEP/dLg.r.), se agruparon de acuerdo con intervalos de edad y se compararon: a)entre sí, mediante análisis de varianza; b)con los valores normativos derivados de NHANES II, para los mismos rangos de edad. El 99%de la población mostró valores normales de Hto, y de FEP/dL g.r. Los promedios de FEP/dLg.r., para los datos agrupados por años de edad cumplida, no presentaron diferencias estadísticamente significativas: 40ñ22; 23ñ17; 25ñ14; 29ñ13; 31ñ15; 29ñ15; 28ñ20; 32ñ12; 30ñ30 (4 a 12 años, respectivamente). Estos valores fueron sensiblemente inferiores a los considerados normales en NHANES II y en el 90%de los casos inferiores a los de su mediana. Se observó correspondencia entre el valor de la mediana y el percentilo 5 de la población norteamericana. Los valores obtenidos para la mediana y percentilo 95 fueron, respectivamente: < 5 años: 25 & 55; 6-8 años: 25 & 57; 9-11 años: 29 & 55; 12-13 años; 29 & 51

Análisis de los valores de protoporfirina eritrocitaria libre, en escolares de una zona urbana de Buenos Aires / Free erythrocyte protoporphyrins study in school-children of Buenos Aires city

El aumento de la Protoporfirina Eritrocitaria Libre (FEP), detecta deficiencias marginales de hierro (Fe), constituyendo un indicador precoz que, a las características de simplicidad y rapidez, une las de su determinación en una muestra mínima de sangre de fácil conservación. Pese a esta ventajas, ha sido poco utilizada en estudios poblacionales, salvo en USA, donde su aplicación en la II Nutritional and National Health Examination Survey (NANHES II), ha permitido establecer valores normativos para las diferentes edades. En este trabajo, se aporta información sobre los valores hallados en una población escolar (n = 102), perteneciente al nivel socio-económico bajo y medio-bajo de la ciudad de Buenos Aires, en la que se determinó Hematocrito (Hto) y FEP (según Piomelli). Los resultados, expresados como FEP/dL de glóbulos rojos (FEP/dLg.r.), se agruparon de acuerdo con intervalos de edad y se compararon: a)entre sí, mediante análisis de varianza; b)con los valores normativos derivados de NHANES II, para los mismos rangos de edad. El 99%de la población mostró valores normales de Hto, y de FEP/dL g.r. Los promedios de FEP/dLg.r., para los datos agrupados por años de edad cumplida, no presentaron diferencias estadísticamente significativas: 40ñ22; 23ñ17; 25ñ14; 29ñ13; 31ñ15; 29ñ15; 28ñ20; 32ñ12; 30ñ30 (4 a 12 años, respectivamente). Estos valores fueron sensiblemente inferiores a los considerados normales en NHANES II y en el 90%de los casos inferiores a los de su mediana. Se observó correspondencia entre el valor de la mediana y el percentilo 5 de la población norteamericana. Los valores obtenidos para la mediana y percentilo 95 fueron, respectivamente: < 5 años: 25 & 55; 6-8 años: 25 & 57; 9-11 años: 29 & 55; 12-13 años; 29 & 51